The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.
about
Guideline of Chronic Urticaria BeyondThe Effectiveness and Safety of Acupuncture for Patients with Chronic Urticaria: A Systematic ReviewTreatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastineAdvances in Understanding and Managing Chronic UrticariaRole of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statementChronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapyProfile of omalizumab in the treatment of chronic spontaneous urticariaAcupuncture for patients with chronic urticaria: a systematic review protocolImmunoglobulin E in irritable bowel syndrome: another target for treatment? A case report and literature reviewImmunological events in chronic spontaneous urticariaManagement of urticaria: not too complicated, not too simpleChronic urticaria in adults: state-of-the-art in the new millenniumApproaches to the diagnosis and management of chronic urticaria in childrenTreatment of Refractory Chronic UrticariaAquagenic urticaria: diagnostic and management challengesBradykinin: Inflammatory Product of the Coagulation SystemQuestions and answers in chronic urticaria: where do we stand and where do we go?Heat urticaria: a revision of published cases with an update on classification and management.Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseasesSense of coherence as a protective factor in chronic urticaria.Increased cis-to-trans urocanic acid ratio in the skin of chronic spontaneous urticaria patients.Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in Ecuador.Increased Risk of Chronic Spontaneous Urticaria in Patients With Autoimmune Thyroid Diseases: A Nationwide, Population-based Study.A rapid method of detecting autoantibody against FcεRIα for chronic spontaneous urticaria.In the memory of Professor Felicidad Cua-Lim.Chronic spontaneous urticaria and internal parasites--a systematic review.Omalizumab in children.The care pathway for children with urticaria, angioedema, mastocytosisClinical similarities among bradykinin-mediated and mast cell-mediated subtypes of non-hereditary angioedema: a retrospective study.Successful and Safe Treatment of Chronic Spontaneous Urticaria with Omalizumab in a Woman during Two Consecutive Pregnancies.Insights and advances in chronic urticaria: a Canadian perspective.Treatment of solar urticaria using antihistamine and leukotriene receptor antagonist combinations tailored to disease severity.Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic Risk.Retrospective case note review of chronic spontaneous urticaria outcomes and adverse effects in patients treated with omalizumab or ciclosporin in UK secondary care.ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria.Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria.Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature.A study of treatment adherence and quality of life among adults with chronic urticaria in Singapore.The Impact of Chronic Urticaria from the Patient's Perspective: A Survey in Five European Countries.
P2860
Q26743369-0C3E3622-169D-4DF8-89DE-4E0E3DCF2462Q26744555-9F680C64-13C3-4BFD-AB9D-C2601AD6FA2FQ26750723-924E8C35-B8C6-47DF-B0EF-C4E57DB5312AQ26767461-7DFCE00E-694B-4418-B8C1-AC0A424B174AQ26769045-B45E7DB0-8E3D-4C3A-A903-10F041AC832CQ26777088-CD859474-14AC-4BE0-94D6-E5C0E0F250D4Q26783158-C122246A-C1E4-4C0D-AB0A-838E505C375EQ26785661-3F44D3DE-7256-474A-AC64-90A116A870A2Q26795564-67BDD55F-8B60-44C3-8EAC-5C82604CFF80Q26796886-7B5A044D-9572-4486-A6FE-CD5F00164A6EQ26828373-9C8DA245-C3A5-4E18-90FE-AC1026E0091AQ26849258-1BB08D3D-B70D-4D9A-AA3A-CBA99AD710D8Q26852686-A86991C8-8D31-4EE6-9CBA-E43A27D4854CQ26865314-3DFD8F58-E347-4E76-9E08-B6050A969393Q28069329-1F1E48D7-A095-46E9-AD76-DCE3B324722DQ28072738-57068DE5-4B87-4359-B1B9-8052B95E96A3Q30249703-A7334CEC-B126-46BB-B6B9-6E778DDC947BQ33166940-6BC1ED04-894B-45D3-B341-4F3EB0372F54Q33588223-2929D41E-61E8-4C27-B906-D15BA74C6A87Q33625914-5C9E915B-5B9E-4565-94F0-AF510C8FD2D2Q33645883-F6DA8F7C-DE7E-4DB4-B372-D894C5A89795Q33683786-430E8962-BA77-4E89-A0E3-D653FFAA0E82Q33716563-35411D97-5167-4AF9-8257-0A2F703FC0C7Q33734366-CE193E50-E561-4164-8771-07F0345B963AQ34343584-005A45E6-AB37-442D-86DF-7829714BF0BCQ34432060-009DF09F-AC72-4CE9-A946-DAE60456A31CQ34504507-E7B3931B-07B0-4B59-8AEA-2A37FC4C7600Q34604574-7D958823-265E-475A-A56B-CD04FC9AEF89Q35036770-AA55ED90-DF66-49CB-BB72-36132B18F351Q35060529-9C4B7C2B-E76B-499A-955B-0F561301EFE6Q35078702-07999042-4FDC-42A6-8A8D-CE2CBAD3B5B2Q35108534-EDF12F28-A5A7-40A6-8F6A-146938074538Q35656087-7C3FE796-BD53-4525-958E-978267AA26AEQ35658142-BCEB1FDE-A363-4F83-B0D2-F6C082A3A96BQ35865960-EF0D8318-94EC-4154-9F3C-F2D442710C03Q35961702-73C901FD-098D-47C1-A5CA-B5E375D658C7Q36016733-C50E3F26-EAAD-4C4E-BC2F-AF9A2E0D6886Q36082959-842EF6EA-DA33-418F-B420-3CA03370B959Q36241656-0CC6F6B0-26B3-4DE0-BBF1-2A7051E4BFC1Q36327840-2CC5B6FA-C21D-4E48-8F4B-6BE6A6E2E60A
P2860
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The EAACI/GA(2) LEN/EDF/WAO Gu ...... the 2013 revision and update.
@en
type
label
The EAACI/GA(2) LEN/EDF/WAO Gu ...... the 2013 revision and update.
@en
prefLabel
The EAACI/GA(2) LEN/EDF/WAO Gu ...... the 2013 revision and update.
@en
P2093
P2860
P50
P356
P1433
P1476
The EAACI/GA(2) LEN/EDF/WAO Gu ...... the 2013 revision and update.
@en
P2093
A Giménez-Arnau
A H Abdul Latiff
European Academy of Allergy and Clinical Immunology
European Dermatology Forum
F E R Simons
P2860
P304
P356
10.1111/ALL.12313
P50
P577
2014-04-30T00:00:00Z